Review of transgender patients who began medical care before age 18 at Strasbourg University Hospital
Official title: Retrospective Single-center Study of the Cohort of Transgender Patients Who Began Medical Support Before the Age of 18 at the Strasbourg University Hospital
Run by University Hospital, Strasbourg, France · NCT07163832 · Data updated 2026-11-12
This project looks back at hospital records to see what happened for transgender patients who started care before age 18 at Strasbourg University Hospital.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 8 Years to 17 Years |
| Sex | All |
| Enrollment | 115 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | May 15, 2025 |
| Main results expected | May 2026 |
| Study ends | May 15, 2026 |
| Registry record updated | September 9, 2025 |
| Trial ID | NCT07163832 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people who first sought transgender-related care at Strasbourg CHU before their 18th birthday, whose medical records are available at the hospital, and who (or whose legal representative) did not object to reuse of their data for research.
✕Probably not a fit
Patients who first presented after age 18, who have incomplete medical records at CHU Strasbourg, or who objected to reuse of their data will not be included and therefore will not derive direct benefit from this analysis.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a retrospective chart review of patients who first presented for transgender-related care before age 18 at Strasbourg University Hospital's child psychiatry and/or pediatric endocrinology services. Investigators will extract de-identified information from medical records, including demographics, clinical presentations, treatments recorded, and available follow-up data, for patients whose records are complete and who did not oppose reuse of their data. Patients with insufficient data or who objected to data reuse will be excluded. The analysis aims to describe care pathways and outcomes in this single-center cohort to inform local clinical practice and future research.
Why it matters
Potential benefit: If successful, this work could clarify typical care pathways and short-term outcomes for transgender youth treated at a major French pediatric center, which may help clinicians and families make more informed decisions.
How similar studies have gone: Other retrospective cohorts of transgender youth have been published and provided descriptive insights into care patterns and short-term outcomes, but long-term, controlled evidence remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Minor patient (≥18 years old) * First-time patient for transgender issues at the Strasbourg University Hospital in child psychiatry and/or pediatric endocrinology (in at least one of the two departments) * Patient (and/or their legal representative) who has not expressed opposition to the reuse of their data for scientific research purposes. Exclusion Criteria: * Patient (and/or their representative) who has expressed opposition to the reuse of their data for scientific research purposes. * Patient aged over 18 at the first consultation * Patient with insufficient data
Where it's running
-
Service de pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: François BREZIN, MD
- Email: francois.brezin@chru-strasbourg.fr
- Phone: 03.88.12.77.34
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.